HOME >> MEDICINE >> NEWS
Subanalysis finds patient-controlled, transdermal pain management system may be comparable

Phoenix, Arizona, November 15, 2004 - Researchers have reported that IONSYSTM, a novel patient-controlled, transdermal, analgesic system that delivers fentanyl through the skin, may be comparable to intravenous patient-controlled analgesia (IV PCA) when used after gynecologic surgery. This needle-free system for managing acute pain in the hospital setting is currently under review by the Food and Drug Administration (FDA), and was granted approvable status in June, 2004. These data were presented at the American Society of Regional Anesthesia & Pain Medicine Annual Fall Pain Meeting.

This research is a subanalysis of a broader, head-to-head study published earlier this year in the Journal of the American Medical Association (JAMA). The complete set of data showed that 316 adult patients receiving IONSYSTM following major surgery experienced similar pain relief as that experienced with IV PCA morphine. This subanalysis focuses on the women in the study who had undergone gynecologic surgery. Patients received either IONSYSTM fentanyl HCl 40mcg -- a system that is designed to be the first and only needle-free, patient-controlled, transdermal analgesic to treat acute pain -- or the current standard of therapy, morphine via IV PCA. IONSYSTM currently is under development and not yet commercially available.

Researchers reported no statistically-significant differences between the two methods in patients' overall pain control, the amount of supplemental pain medication required, or the number of patients withdrawing from the study due to inadequate pain relief. Side effects were similar in both groups.

"In 2002, there were more than a million gynecologic surgeries performed in the United States," said Shireen Ahmad, M.D., Assistant Professor, Department of Anesthesiology at Northwestern University. "In this subanalysis, IONSYSTM provided post-operative pain relief to most patients und
'"/>


15-Nov-2004


Page: 1 2 3

Related medicine news :

1. Study finds that coordinating care of chronically ill patients does not increase liability
2. Bullying among sixth graders a daily occurrence, UCLA study finds
3. Study finds factors linked to substance use disorder relapse among health care professionals
4. Study finds majority of women willing to accept cervical cancer vaccine for self and children
5. Boston University team finds link between high cholesterol and better cognitive performance
6. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
7. Study finds direct association between cardiovascular disease and periodontal bacteria
8. Emory Study finds HIV is not an independent risk factor for severe heart disease
9. Study finds indoor allergen levels vary, cockroach allergens cause more asthma symptoms
10. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis
11. Men more likely to get screened for prostate cancer than colon cancer, U-M study finds

Post Your Comments:
(Date:4/21/2015)... 2015 Invictus Medical has secured ... university for a second innovative technology aimed at ... to newborn infants’ cognitive development. , “This technology ... we have identified through extensive interviews and input ... Hutchinson, Invictus Medical’s Chief Technology Officer. “We believe ...
(Date:4/20/2015)... Heritage Woods of Centralia, a Gardant affordable assisted ... Spaghetti Dinner from 4 p.m. to 6 p.m. on ... Centralia, Illinois, houses senior living apartments, affordable assisted living ... older. , Guests are invited to tour the community ... seniors. After the tours, they can take home spaghetti ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 Reality show ... and girlfriends at the twentieth annual Michigan International Women’s ... in Novi. , “There is lots to see and ... to shopping for fashion and gifts,” said Beth Anderson, ... are entertaining and encouraging with appearances from Randy Fenoli ...
(Date:4/20/2015)... The partners of Urgent Care of Westchester and Riverdale ... Med Spa with a special event. Residents of Westchester County ... p.m. on April 24 on 909 Midland Ave. in Yonkers, ... will also get the chance to win free services from ... purchase, as well as up to 40 percent discounts on ...
(Date:4/20/2015)... The American Association for Physician Leadership® ... Improvement as the 2015 winner of the Leape Ahead ... Meeting, April 18, in Las Vegas, Nevada. , ... safety can be dramatically improved,” said Peter Angood, MD, ... Medicine and its Academy for Quality and Safety should ...
Breaking Medicine News(10 mins):Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3Health News:Bella Diosa Says Hello to Yonkers Community with Spa Party 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 3
(Date:4/20/2015)... Calif. , April 20, 2015  Published ... positive trends in the ability of Neuraltus ... progression of amyotrophic lateral sclerosis (ALS, also known ... 6-month treatment period. While NP001,s slowing of decline ... study was not statistically significant, clinically meaningful slowing ...
(Date:4/20/2015)... April 20, 2015  OpGen, Inc., a molecular ... of its executive management team with the appointments ... executive Kevin Krenitsky , M.D. as president, ... chief financial officer. With more ... global diagnostic and biotechnology operations, including senior commercial ...
(Date:4/20/2015)... , April 20, 2015 ... disease and specifically autism drug candidates, a few viable ... such as fragile X syndrome.   Biotech Companies in ... (NASDAQ: CYTR ), Trovagene, Inc., (NASDAQ: TROV ... Laboratories (NYSE: ABT ) & Lexicon Pharmaceuticals, Inc. ...
Breaking Medicine Technology:Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 2OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 3OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 4Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 2Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 3Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 4Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 5Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 6
Cached News: